Drawing for AVVINITY

USPTO serial 79323648

AVVINITY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MASON, JARED MICHAEL
Law office
TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AVVINITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
040Custom manufacture of therapeutic drugs, including custom manufacture of antibody based therapies and cancer therapiesACTIVE—
042Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and pharmaceutical research services; biological research; biotechnology testing services; scientific research in the field of oncology; development of pharmaceutical preparations and medicines; development of new cancer therapies; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical trials; clinical trial design for vaccines and gene therapy; scientific research in human and animal cell therapy; research and development services relating to targeting therapies to individuals; scientific research into preparations for manipulating and adapting human and animal cells; software as a service; providing a bioinformatics platform for manufacturing therapeutics; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; research and development of new products for others; development of pharmaceutical products for others; information, advisory and consultancy services relating to the aforesaidACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 30, 2024FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 10, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 10, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 12, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 22, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 22, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 10, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 10, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 10, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 19, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 27, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 27, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 7, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2022DOCKASSIGNED TO EXAMINER—
Oct 30, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 26, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 22, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance